Peter Strothman has spent his career investing in the healthcare and private equity industries, completing strategic transactions totaling more than $3 billion in value. He focuses on investing and creating value in companies specializing in life sciences, specialty pharmaceutical products and services, and general healthcare products and outsourced services. Most recently, Peter has worked to build a leading group of pharmaceutical companies for Water Street and a new corporate partnership program that supports pharmaceutical companies with maximizing their research and development investments. Prior to Water Street, Peter was a principal with JLL Partners, where he focused exclusively on healthcare investments. He began his career in the Global Mergers and Acquisitions group of Lehman Brothers. Peter currently serves as chairman of CCBR-SYNARC and a director of Celerity Pharmaceuticals. He is a former director of AAIPharma Services and OraPharma. Peter received a bachelor’s degree in economics from Harvard University.